Supervisory Board

ENGLISH DEUTSCH

Prof Christof Hettich, LLD (Chairman)

Partner at RITTERSHAUS Lawyers
Managing Director dievini Hopp BioTech holding GmbH & Co. KG

Professor Christof Hettich has been a member of the Supervisory Board since 21 May 2010, was re-elected on 30 July 2015 and is its current Chairman. Professor Hettich is a lawyer and partner at RITTERSHAUS Rechtsanwälte in Mannheim/Frankfurt/Munich. He studied law and political science at the Universities of Freiburg, Würzburg and Mannheim, obtaining his PhD from the University of Würzburg. Professor Hettich has extensive experience in arranging M&A transactions as well as in the structuring and restructuring of medium-sized and public companies. He manages the procurement of private equity financing including the preparation of share issues in sectors such as biotechnology and medical technology. Professor Hettich is co-founder and Managing Director of dievini Verwaltungs GmbH, which in turn acts as the manager of dievini Hopp BioTech holding GmbH & Co. KG.

Georg F. Baur, PhD (Deputy Chairman)

Entrepreneur

Dr Georg F. Baur was re-elected to the Supervisory Board on 30 July 2015 and is its current Deputy Chairman. He had already held this position from 28 August 2003 to 30 July 2015 after serving as the Supervisory Board’s chairman from 14 December 2000 to 28 August 2003. Dr Baur works as an entrepreneur in the areas of private investments and asset management. Between 1990 and 1992 he was Managing Partner of Lehndorff Vermögensverwaltungs GmbH. From 1979 to 1989 Dr Baur held various positions at JP Morgan, ultimately as Managing Director and Treasurer of the bank in London. He holds a PhD from the University of St. Gallen, Switzerland.

Friedrich von Bohlen und Halbach, PhD

Managing Director dievini Hopp BioTech holding GmbH & Co. KG

Dr Friedrich von Bohlen und Halbach has been a member of the Supervisory Board since 29 April 2005 and was re-elected on 30 July 2015. Since 2005 he has served as Managing Director of dievini Verwaltungs GmbH, which in turn acts as the manager of dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, a company that supports and mentors SAP founder Dietmar Hopp in his investments in life sciences and advises the companies from the industry in which Mr Hopp invests on their corporate and business development. In 1997 he co-founded LION bioscience AG, Heidelberg, where he served as CEO until 2003 and of which he has been Chairman of the Supervisory Board since 2004. From 1994 to 1997 he served as CEO of WASAG Chemie AG, Essen. Mr von Bohlen und Halbach began his career in 1992 as a project manager for the Research & Development division of Fresenius AG, Bad Homburg, following which he was assistant to the chairman of the Supervisory Board of FAG Kugelfischer KGaA, Schweinfurt. He studied biochemistry and business management in Zurich, Switzerland, and received a PhD in neurobiology from the Swiss Federal Institute of Technology in 1992.

Dr Birgit Kudlek

COO und CDO AENOVA Holding GmbH

Dr Birgit Kudlek has been a member of the Supervisory Board since 25 May 2012 and was re-elected on 30 July 2015. Dr Kudlek has served as Chief Operating and Chief Development Officer as well as Managing Director of AENOVA Holding GmbH in Starnberg since February 2014. In this role she is responsible for the group’s 18 production facilities as well as for 4 development centers. From 2009 to 2013 she was Head of the Sandoz Development Center Network at Sandoz International in Holzkirchen, Germany, since May 2009. In this role she had global responsibility for all development activities of the company’s 9 development centers in 6 countries. From 2007 to 2008 she was an Executive Board Member of LTS Lohmann Therapie-Systeme, Andernach, Germany, where she was responsible for Technical Operations and Quality. From 2003 to 2007 Dr Kudlek worked for ratiopharm, Ulm, Germany, in various management positions within Technical Operations and Development, before taking over responsibility for global development activities. Prior to that Dr Kudlek was employed for more than 4 years as a consultant at Accenture, Kronberg, Germany. She started her career as Managing Assistant at Hoechst Marion Roussel, today Sanofi Aventis, Frankfurt, Germany. Birgit Kudlek studied Pharmaceutical Science as well as Economics and holds a PhD in Pharmaceutical Technology from the Technical University of Braunschweig, Germany.

Dr Mathias Hothum

Managing Director of dievini Hopp BioTech holding GmbH & Co. KG

Dr Mathias Hothum was elected by the Annual General Meeting on 30 July 2015. Dr Hothum, together with Christof Hettich and Friedrich von Bohlen serves as Managing Director of dievini Verwaltungs GmbH, which in turn acts as the manager of dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, a company that supports and mentors SAP founder Dietmar Hopp in his investments in life sciences and advises the companies from the industry in which Mr Hopp invests on their corporate and business development. His focus is on controlling and strategy planning of portfolio companies. Since 1992 Dr Mathias Hothum is owner and managing director of HMM Consulting in Walldorf. With his expertise and experience of twenty years as a self-employed consultant in the area of health care he advised not only companies. He also shared his expertise with students as a lecture at the SRH Hochschule Heidelberg. Dr Hothum received his diplom degree in Economics from the University of Mannheim. He went on to do his doctorate at the University of Magdeburg.

Seite gelesen: 2800 | Heute: 8